SABA inhaler carbon emissions have dropped by one-third since 2020, NHS England data show Exclusive: Pharmacy experts said the fall in short-acting beta-2 agonist inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.…
C. difficile cases increase by one-third over three years, government data show Data from the UK Health Security Agency (UKHSA) show that a three-year increase in Clostridioides difficile infections in England was observed across all seven UKHSA regions.…
Almost 80% of pharmacies receive inappropriate antibiotic requests every day, reveals survey The majority of pharmacies surveyed by the National Pharmacy Association also said they were worried that demand for antibiotics for minor ailments “posed a serious risk to patient safety”.…
Repeat prescription opioids most commonly linked to patient harm and deaths, study results show Researchers found that between January 2019 and December 2023, opioid analgesics made up 76% of the medications mentioned in coroners’ prevention of future deaths reports.…
Pancreatic exocrine insufficiency: causes, diagnosis and treatment An overview of the causes, diagnosis and treatments for pancreatic exocrine insufficiency, including a case study of a patient’s experience.…
New antibiotic already causing AMR concerns, study results suggest Researchers also found that ceftazidime with avibactam-resistant bacteria coincided with the presence of carbapenemase genes.…
MHRA to review blood monitoring requirements for clozapine patients Starting in summer 2025, the Medicines and Healthcare products Regulatory Agency will seek views on ways to improve awareness of patient risks related to clozapine.…
Neonatal sepsis: prevention and management The third article in a series on complications associated with prematurity and unwell neonates.…
Antibiotic could help tackle drug-resistant gonorrhoea, study results suggest Researchers found that gepotidacin was as effective as the current recommended first-line therapy for gonorrhoea.…
Earlier treatment with combination of drugs could prevent 5,000 heart attacks per decade, study results suggest Researchers found that patients who received a combination treatment of statins and ezetimibe within 12 weeks of a heart attack and lowered their cholesterol to target-level early were less at risk of heart attacks, strokes and deaths.…
